Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/1995
10/18/1995CN1110157A Health-care medicinal bag for children
10/18/1995CN1110150A Jiawei double coptis medicament and preparing method thereof
10/18/1995CN1110147A Antiallergic composition
10/18/1995CN1110146A Quick-acting Kouchuang powder for curing aphthosis
10/18/1995CN1110145A Scorpion venom oil for curing dermatosis
10/18/1995CN1110101A Xuege oral liquor and its preparation method
10/18/1995CN1030067C Method for preparation of natural seawater inorganic metal ion and trace element concentrated liquid
10/18/1995CN1030033C Method for preparation of soft-shelled turtle tonic health-care product
10/17/1995US5459058 Eukayrotic cell cultures dependent on interleukins for survival
10/17/1995US5458875 In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
10/17/1995CA1337346C Process for preparing 1,5-benzothiazepine derivatives
10/17/1995CA1337337C Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity
10/17/1995CA1337330C Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
10/12/1995WO1995027046A2 Enzymatic antimicrobial compositions containing haloperoxidases
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995027043A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995WO1995027042A1 Genetically modified cells for use in transplantation
10/12/1995WO1995026800A1 Body fluid filtration device and application thereof
10/12/1995WO1995026742A1 Immunotherapeutic agent and its use
10/12/1995WO1995026741A1 Cells with multiple altered epitopes on a surface antigen for use in transplantation
10/12/1995WO1995026740A1 Improved methods for transplantation using modified cells and t cell inhibitory agents
10/12/1995CA2186962A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995CA2186529A1 Cells with multiple altered epitopes on a surface antigen for use in transplantation
10/12/1995CA2186528A1 Genetically modified cells for use in transplantation
10/12/1995CA2186527A1 Improved methods for transplantation using modified cells and t cell inhibitory agents
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/12/1995CA2182966A1 Enzymatic antimicrobial compositions
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675956A1 New protein from urine named component b
10/11/1995EP0675752A1 System and method for processing separate containers of biological fluid
10/11/1995EP0675728A1 Products and methods for improving keratinocyte adhesion to the dermis
10/11/1995EP0675726A1 Megakaryocyte and platelet growth, production and composition
10/11/1995EP0629129A4 Method for kidney tubulogenesis.
10/11/1995EP0612238B1 A container for receiving and separating a fluid, preferably blood plasma, into its ingredients
10/11/1995EP0538330B1 Beta-alethine use in cell culture and therapy
10/11/1995CN1109774A Medicated wine composition for curing sciatica
10/11/1995CN1109763A Vaccinal efficacy augmentor and efficacy-augmenting foods
10/11/1995CN1109762A Oral white ant liquid and preparing process thereof
10/11/1995CN1109748A Rapamycin formulation for IV injection
10/11/1995CN1029977C Human insulin analogues
10/10/1995US5457181 Preparation of a high-purity human factor IX concentrate and other plasmatic proteins and their therapeutic use
10/10/1995US5456935 Food products
10/10/1995US5456924 Method of treatment of HIV-seropositive individuals with dietary whey proteins
10/10/1995CA2042032C Therapeutic agent and method of inhibiting vascularization of tumors
10/10/1995CA1337265C Oral antibody therapy for patients with lowered immune response and composition therefor
10/05/1995WO1995026412A1 Ligands added to adenovirus fiber
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026344A1 Sesquiterpenic derivatives
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995DE4411108A1 Use of co-fermented milk prods. to prepare medicaments
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/04/1995EP0674905A2 Bacterin for the treatment of necrophorum diseases and a method for the production thereof
10/04/1995EP0674531A1 Process for preparing a virus-safe biological composition
10/04/1995EP0674523A1 Topical composition containing garlic oil
10/04/1995EP0674497A1 Microporous macrocapsules
10/04/1995EP0635040A4 Crosslinked biocompatible encapsulation compositions and methods.
10/04/1995CN1109359A Chinese prepared medicine for curing apoplexy
10/04/1995CN1109358A Instant powder for replenishing qi and blood and its producing method
10/04/1995CN1109357A Cosmetic health products and art method
10/04/1995CN1109350A Skin medicine
10/04/1995CN1109341A Medicine for curing scald and burn
10/04/1995CN1109338A Biological yin and yong medicine for regulating human body balance
10/03/1995US5455028 Method of inhibiting fungi by Bacillus laterosporus
10/01/1995CA2120385A1 Tissue-equivalent membrane from bovine esophageal tissue
09/1995
09/28/1995WO1995025807A1 Inhibition of arterial smooth muscle cell proliferation
09/28/1995WO1995025806A2 Packaging-deficient lentiviruses
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995WO1995025748A1 Topical fibrinogen complex
09/28/1995WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/28/1995WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995WO1995025574A1 Method and porous support for removing contaminants
09/28/1995WO1995025531A1 Means for treating auto-immune diseases and method of treatment
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995WO1995025527A1 Novel clay-based medicinal composition
09/28/1995WO1995025523A1 Novel pharmaceutical composition for skin diseases
09/28/1995CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995CA2185892A1 Means for treating auto-immune diseases and method of treatment
09/28/1995CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/28/1995CA2162997A1 Topical fibrinogen complex
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673653A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it
09/27/1995EP0673652A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it
09/27/1995EP0673651A1 Novel drug composition based on clay
09/27/1995EP0673643A1 Cosmetic composition containing an association of superoxide dismutase and porphyrine
09/27/1995EP0673259A1 A method for transplanting cells into the brain and therapeutic uses therefor
1 ... 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 ... 1259